Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Pharmaceuticals
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
CVS to Shed 5,000 Jobs in Cost-Cutting Push
The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. Source link
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Eli Lilly to Acquire Obesity-Treatment Maker Versanis
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain...
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Walgreens Lowers Financial Outlook Amid Weaker Retail Consumer Spending
The drugstore chain says it will step up cost-cutting measures and boost the long-term profitability of its healthcare business. Source...
Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley.
Listen to article(2 minutes)Elon Musk takes ketamine. Sergey Brin sometimes enjoys magic mushrooms. Executives at venture-capital firm Founders Fund, known...
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
Research suggests fungicides are weakening antifungals before they are up for approval. Source link
No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming
Tablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require. Source link
Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions
Novo Nordisk accused the firms of false advertising, trademark infringement and unfair competition. Source link
U.S. Chamber of Commerce Challenges Federal Government’s New Drug-Price Powers
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
WSJ News Exclusive | Baby-Formula Makers Face FTC Investigation for Collusion
The agency is investigating whether any formula manufacturers coordinated before bidding for state contracts. Source link
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
ShareListen(2 min) Source link
FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
In China, a Detention and a New Espionage Law Have Businesses Worried
Foreign companies are growing more concerned about the safety of their staffs and the reliability of Beijing’s pledges that China...
WSJ News Exclusive | J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market
The company is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a test for an...
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
